Literature DB >> 12507210

Colorectal metastasis (liver and lung).

Christophe Penna1, Bernard Nordlinger.   

Abstract

Distant metastases are the major cause of death for colorectal carcinoma patients. Depending on the primary tumor's stage, liver metastases occur in 20% to 70% of patients and lung metastases in 10% to 20%. Unlike many other cancers, the presence of distant metastases from colorectal cancer does not preclude curative treatment. Surgical resection remains the only treatment that can ensure long-term survival and cure in some patients, but only a minority of liver metastases are amenable to surgery. New treatment modalities including portal vein embolization, perioperative chemotherapy and local destruction with cryotherapy or radiofrequency ablation may make more patients suitable for surgical resection of hepatic metastases and may prolong survival in cases of nonresectabilitv. The availability of new active drugs has changed the treatment of liver metastases from colorectal cancer.

Entities:  

Mesh:

Year:  2002        PMID: 12507210     DOI: 10.1016/s0039-6109(02)00051-8

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  73 in total

Review 1.  Hepatic radiation toxicity: avoidance and amelioration.

Authors:  Chandan Guha; Brian D Kavanagh
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

2.  Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT.

Authors:  L Bacigalupo; S Aufort; M C Eberlé; E Assenat; M Ychou; B Gallix
Journal:  Radiol Med       Date:  2010-06-23       Impact factor: 3.469

Review 3.  Radiation-associated liver injury.

Authors:  Charlie C Pan; Brian D Kavanagh; Laura A Dawson; X Allen Li; Shiva K Das; Moyed Miften; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 4.  Treatment for multiple bilobar liver metastases of colorectal cancer.

Authors:  Hiroshi Shimada; Kuniya Tanaka; Kenichi Matsuo; Shinji Togo
Journal:  Langenbecks Arch Surg       Date:  2005-12-01       Impact factor: 3.445

5.  Functions and regulation of MUC13 mucin in colon cancer cells.

Authors:  Brij K Gupta; Diane M Maher; Mara C Ebeling; Phillip D Stephenson; Susan E Puumala; Michael R Koch; Hiroyuki Aburatani; Meena Jaggi; Subhash C Chauhan
Journal:  J Gastroenterol       Date:  2013-10-07       Impact factor: 7.527

6.  Reoperation for recurrent colorectal cancer.

Authors:  Michael D Hellinger; Cesar A Santiago
Journal:  Clin Colon Rectal Surg       Date:  2006-11

7.  Thoracic recurrence in patients with curatively-resected colorectal cancer: incidence, risk factors, and value of chest CT as a postoperative surveillance tool.

Authors:  J H Lee; Chang Min Park; I Joo; Y J Suh; E J Hwang; H Kim; J M Goo
Journal:  Eur Radiol       Date:  2018-10-22       Impact factor: 5.315

8.  The Glasgow prognostic score is valuable for colorectal cancer with both synchronous and metachronous unresectable liver metastases.

Authors:  Kenei Furukawa; Hiroaki Shiba; Koichiro Haruki; Yuki Fujiwara; Tomonori Iida; Yoshinobu Mitsuyama; Masaichi Ogawa; Yuichi Ishida; Takeyuki Misawa; Katsuhiko Yanaga
Journal:  Oncol Lett       Date:  2012-05-17       Impact factor: 2.967

9.  Elevated O-GlcNAcylation of Extracellular Vesicle Proteins Derived from Metastatic Colorectal Cancer Cells.

Authors:  Parunya Chaiyawat; Churat Weeraphan; Pukkavadee Netsirisawan; Daranee Chokchaichamnankit; Chantragan Srisomsap; Jisnuson Svasti; Voraratt Champattanachai
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

Review 10.  Management of resectable colorectal lung metastases.

Authors:  Sing Yu Moorcraft; George Ladas; Anne Bowcock; Ian Chau
Journal:  Clin Exp Metastasis       Date:  2015-12-10       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.